Spring D B, Barkan H E, Pruyn S C
Department of Diagnostic Imaging, Kaiser Permanente Medical Center, Oakland, CA 94611-5693, USA.
Radiology. 2000 Jan;214(1):53-7. doi: 10.1148/radiology.214.1.r00ja2353.
To evaluate the influence of the contrast material used in hysterosalpingography (HSG) on subsequent reproductive success, independent of other therapeutic interventions.
In a prospective, multisite, randomized trial, 666 women who had been infertile for more than 1 year and were scheduled to undergo HSG as part of their evaluation were assigned to one of three groups: those receiving water-soluble contrast material (WSCM) (n = 260), those receiving oil-soluble contrast material (OSCM) (n = 273), and those receiving both OSCM and WSCM (n = 133). Possible causes of infertility and therapeutic interventions were abstracted from the medical records. Data on conception within 1 year and the outcome of conception were ascertained from multiple sources.
Of 666 women, 204 (30.6%) had at least one pregnancy, and 136 (20.4%) had live births. The rates of live births were 20.4% (54 of 260) after HSG with WSCM, 19.4% (53 of 273) after HSG with OSCM, and 21.8% (29 of 133) after HSG with both WSCM and OSCM. Differences in reproductive outcome among contrast material groups were not statistically significant ((chi2)8 = 6.08, P = .64). Whatever the cause of infertility, the use of different contrast materials led to no significant differences in the rates of live births.
There is no evidence to suggest that the choice of contrast material affects the rate of term pregnancy.
评估子宫输卵管造影术(HSG)中使用的造影剂对后续生殖成功率的影响,不考虑其他治疗干预措施。
在一项前瞻性、多中心、随机试验中,将666名不孕超过1年且计划接受HSG作为评估一部分的女性分为三组:接受水溶性造影剂(WSCM)的女性(n = 260)、接受油溶性造影剂(OSCM)的女性(n = 273)以及接受OSCM和WSCM两者的女性(n = 133)。从病历中提取不孕的可能原因和治疗干预措施。通过多种来源确定1年内受孕数据和受孕结局。
666名女性中,204名(30.6%)至少有一次怀孕,136名(20.4%)有活产。使用WSCM进行HSG后活产率为20.4%(260名中的54名),使用OSCM进行HSG后活产率为19.4%(273名中的53名),使用OSCM和WSCM两者进行HSG后活产率为21.8%(133名中的29名)。造影剂组之间生殖结局的差异无统计学意义(χ28 = 6.08,P = 0.64)。无论不孕原因如何,使用不同造影剂导致活产率无显著差异。
没有证据表明造影剂的选择会影响足月妊娠率。